Want to join the conversation?
Dan Leonard of Leerink Partners asks for an update about European business trends. $A SVP Pat Kaltenbach said the company has seen growth in Central Europe and weakness in Eastern Europe, mainly driven by the energy market. He added there is strength in Germany and other states around that, with academia & government flat and strong pharma growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?